First Degree Maximum Strength Burn

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: First Degree Maximum Strength Burn
Generic name: PRAMOXINE HYDROCHLORIDE
Manufacturer: Welmedix LLC
Product type: HUMAN OTC DRUG
SPL set ID: 1afa337e-f411-42df-b2f5-5f72c9b52ffa
SPL ID: cbfe71fd-2d5c-4c98-8caf-68fe49e54b6f
Version: 1
Effective date: 2017-03-09
Source export date: 2026-10-30
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/8d15bdc5962e7531569eaeb5b1b2e4919574d40a6782ab67345a27b890175a00/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:55:31

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		part348	openfda.application_number
brand name		First Degree Maximum Strength Burn	openfda.brand_name
generic name		PRAMOXINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		Welmedix LLC	openfda.manufacturer_name
ndc	package	24330-130-02	openfda.package_ndc
ndc	product	24330-130	openfda.product_ndc
ndc11	package	24330013002	derived:openfda.package_ndc
rxcui		1052684	openfda.rxcui
spl id		cbfe71fd-2d5c-4c98-8caf-68fe49e54b6f	id
spl set id		1afa337e-f411-42df-b2f5-5f72c9b52ffa	set_id
unii		88AYB867L5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with the eyes Do not use if you are allergic to any of the ingredients over large areas of the body Stop use and ask a doctor if condition worsens symptoms persist for more than 1 week, or clear up and occur again within a few days rash or other allergic reaction develops Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.